Rury R Holman Selected Research

Rury R Holman Research Topics

Disease

107	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2002
43	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 05/2002
29	Myocardial Infarction 01/2023 - 10/2008
28	Heart Failure 01/2023 - 12/2006
24	Stroke (Strokes) 01/2023 - 04/2010
23	Glucose Intolerance 11/2023 - 10/2006
12	Insulin Resistance 01/2023 - 10/2002
9	Atrial Fibrillation 01/2022 - 01/2012
9	Hypoglycemia (Reactive Hypoglycemia) 12/2019 - 02/2002
8	Hypertension (High Blood Pressure) 10/2023 - 11/2004
8	Unstable Angina 01/2023 - 04/2010
7	Coronary Disease (Coronary Heart Disease) 11/2023 - 09/2013
7	Hyperglycemia 01/2022 - 05/2002
7	Diabetes Mellitus 12/2019 - 07/2006
7	Weight Gain 01/2018 - 02/2002
5	Vascular Diseases (Vascular Disease) 07/2023 - 01/2016
5	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2023 - 11/2004
5	Body Weight (Weight, Body) 01/2022 - 02/2002
5	Renal Insufficiency (Renal Failure) 01/2020 - 06/2013
4	Overweight 01/2023 - 11/2006
4	Neoplasms (Cancer) 01/2022 - 11/2017
4	Blindness (Hysterical Blindness) 01/2020 - 06/2013
4	Obesity 01/2020 - 08/2006
4	Pancreatitis 01/2018 - 02/2017
3	Weight Loss (Weight Reduction) 01/2023 - 04/2015
3	Inflammation (Inflammations) 01/2023 - 01/2020
3	Chronic Renal Insufficiency 01/2022 - 11/2017
3	Peripheral Arterial Disease 10/2021 - 03/2009
3	Albuminuria 10/2021 - 06/2006
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020 - 06/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 02/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 08/2006
2	Orthostatic Hypotension (Postural Hypotension) 10/2023 - 01/2021
2	Infections 10/2021 - 01/2020
2	Acute Coronary Syndrome 01/2021 - 01/2020
2	Edema (Dropsy) 01/2018 - 12/2006
2	Bone Fractures (Bone Fracture) 11/2017 - 01/2010
2	Eye Diseases (Eye Disease) 11/2017 - 07/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 01/2017
2	Diabetes Complications 06/2013 - 11/2006
1	Hypotension (Low Blood Pressure) 10/2023
1	Vascular Calcification 07/2023
1	ST Elevation Myocardial Infarction 01/2023

Drug/Important Bio-Agent (IBA)

37	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 08/2002
25	Sitagliptin Phosphate (Januvia)FDA Link 01/2023 - 12/2013
20	Exenatide (Byetta)FDA Link 05/2023 - 04/2016
19	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 10/2002
15	Valsartan (Vals)FDA Link 10/2020 - 10/2008
14	Nateglinide (Starlix)FDA LinkGeneric 10/2020 - 10/2008
13	Insulin (Novolin)FDA Link 01/2022 - 02/2002
10	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2019
9	LipidsIBA 01/2022 - 07/2006
9	LDL CholesterolIBA 10/2021 - 06/2006
8	HDL CholesterolIBA 01/2022 - 05/2002
8	Rosiglitazone (Avandia)FDA Link 05/2011 - 10/2002
7	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024 - 01/2018
7	Acarbose FDA LinkGeneric 11/2023 - 07/2014
7	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2022 - 07/2015
7	CreatinineIBA 01/2022 - 06/2006
7	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 10/2007
6	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2010
6	SodiumIBA 01/2023 - 10/2019
6	Glyburide (Glibenclamide)FDA LinkGeneric 05/2011 - 10/2002
5	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024 - 10/2019
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2013
5	ThiazolidinedionesIBA 10/2020 - 12/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 02/2014
4	empagliflozinIBA 01/2023 - 01/2020
4	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 04/2016
4	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2004
4	C-Reactive ProteinIBA 02/2014 - 10/2002
4	AlbuminsIBA 01/2012 - 10/2002
3	Glycoside Hydrolase InhibitorsIBA 11/2023 - 01/2018
3	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 11/2022
3	Blood Glucose (Blood Sugar)IBA 07/2020 - 02/2014
3	GlucosidasesIBA 01/2020 - 07/2014
3	Retinaldehyde (Retinal)IBA 01/2020 - 11/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2017 - 11/2004
3	CholesterolIBA 01/2012 - 08/2006
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2009 - 12/2006
2	SymportersIBA 01/2023 - 11/2022
2	AutoantibodiesIBA 01/2020 - 11/2006
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019 - 01/2017
2	Angiotensin Receptor AntagonistsIBA 09/2017 - 10/2012
2	Fibrinogen (Factor I)FDA Link 08/2006 - 10/2002
2	AntigensIBA 08/2006 - 10/2002
1	Sodium-Glucose Transport ProteinsIBA 02/2024
1	OsteocalcinIBA 07/2023
1	OsteopontinIBA 07/2023
1	OsteoprotegerinIBA 07/2023
1	Pioglitazone (Actos)FDA Link 01/2023
1	CanagliflozinIBA 01/2023

Therapy/Procedure

40	Therapeutics 02/2024 - 02/2002
11	Glycemic Control 01/2020 - 02/2002
5	Precision Medicine 02/2024 - 01/2018
5	Surgical Amputation (Amputations) 10/2021 - 06/2013
4	Light Coagulation 01/2020 - 11/2002
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
2	Secondary Prevention 11/2017 - 09/2017